A preferred transdermal dosage form which may be used in accordance with the present invention includes a non-permeable backing layer made, for example, of polyester, an adhesive layer made, for example of a polyacrylate; and a matrix containing the buprenorphine and other desirable pharm acetucial acids such as softeners, permeability enhancers, viscosity agents and the like.